April 7, 2025
Evestia Clinical’s Bold New Chapter in Oncology and Rare Disease Research
Evestia Clinical is kicking off with new identity of EMAS Pharma, as it sets its sights on rapid growth as a…
Pharmaceuticals, Biotechnology and Life Sciences
Evestia Clinical is kicking off with new identity of EMAS Pharma, as it sets its sights on rapid growth as a…
A UK biotech company Aelius Biotech whose unique laboratory gut model is used to trial new drugs and foodstuffs without the need for animal testing has raised a further £750,000 from the North East Venture Fund, supported by the European Regional Development Fund and managed by Mercia Ventures.
High Force Research, a leading provider of specialist chemical R&D and manufacturing services, has appointed Dr Nathalie Huther as its new Chief Commercial Officer (CCO), after the company’s most recent Management Buyout (MBO).
CSL Behring and the GKV-Spitzenverband (National Association of Statutory Health Insurance Funds) have successfully concluded negotiations on the reimbursement price…
Company to host conference call on April 7 at 8 a.m. ETBOSTON, April 06, 2025 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals,…
HONOLULU, Hawaii, April 05, 2025 (GLOBE NEWSWIRE) — Arialief is nutritional support specifically designed to offer sciatic nerve relief. It…
NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) — Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases,…
Oral Plenary Presentation on Tuesday, April 8 Features Phase 3 Data for ANX005, the First Potential Targeted Therapy for GBS,…
MELBOURNE, Australia and INDIANAPOLIS, April 04, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company)…
BOSTON, April 03, 2025 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights…